SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

    A-Cienfuegos J (1), Rotellar F (2), Ruiz-Canela M (3). (1) Cirugía/ Apoyo Investigación, Clinica Universidad de Navarra, España.
    (2) Cirugía General y Digestiva, Clinica Universidad de Navarra, España.
    (3) Department of Preventive Medicine and Public Healt, Medical School. University of Navarra, España.

    Revista Española de Enfermedades Digestivas 04 AUGUST 2017

  • The Post-SIR-Spheres Surgery Study (P4S)

    Pardo F (1), Sangro B (2), Lee RC (3), Manas D (4,5), Jeyarajah R (6), Donckier V (7), Maleux G (8), Pinna AD (9), Bester L (10), Morris DL (11), Iannitti D (12), Chow PK (13), Stubbs R (14), Gow PJ (15), Masi G (16), Fisher KT (17), Lau WY (18), Kouladouros K (19), Katsanos G (20), Ercolani G (21), Rotellar F (22), Bilbao JI (23), Schoen M (19). (1) HPB and Transplant Surgery, Clinica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain.
    (2) Liver Unit, Clinica Universidad de Navarra, IDISNA, CIBEREHD, Pamplona, Navarra, Spain.
    (3) Radiology, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan.
    (4) Institute of Transplantation, University of Newcastle Upon Tyne, Newcastle Upon Tyne, UK.
    (5) Newcastle NHS Trust, Newcastle Upon Tyne, UK.
    (6) Surgical Oncology, Methodist Dallas Medical Center, Dallas, TX, USA.
    (7) Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles and Centre de Chirurgie Hépato-Biliaire de l'ULB, Brussels, Belgium.
    (8) Radiology, University Hospitals Leuven, Louvain, Belgium.
    (9) Hepatobiliary and Transplant Surgery, S. Orsola-Malpighi, University of Bologna, Bologna, Italy.
    (10) Interventional Radiology, St Vincent's Hospital, Sydney, NSW, Australia.
    (11) Department of Surgery, St George Hospital, University of New South Wales, Kogarah, NSW, Australia.
    (12) HPB Surgery, Carolinas Medical Center, Charlotte, NC, USA.
    (13) Surgical Oncology, National Cancer Center, Singapore, Singapore.
    (14) Hepatobiliary Surgery, Wakefield Clinic, Wellington, New Zealand.
    (15) Transplant Hepatology, Austin Hospital, Heidelberg, VIC, Australia.
    (16) Medical Oncology, Ospedale Santa Chiara, Pisa, Italy.
    (17) Department of Surgery, Saint Francis Hospital, Tulsa, OK, USA.
    (18) Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, Hong Kong.
    (19) Klinikum Karlsruhe, Karlsruhe, Germany.
    (20) Department of Abdominal Surgery, Hôpital Erasme, Université Libre de Bruxelles and Centre de Chirurgie Hépato-Biliaire de l'ULB, Brussels, Belgium.
    (21) Hepatobiliary and Transplant Surgery, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
    (22) HPB and Transplant Surgery, Clinica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain.
    (23) Interventional Radiology, Clinica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain.

    Annals of Surgical Oncology 26 JUNE 2017

  • IL-32α-induced inflammation constitutes a link between obesity and colon cancer

    Catalán V (1,2,3), Gómez-Ambrosi J (1,2,3), Rodríguez A (1,2,3), Ramírez B (1,2,3), Ortega VA (1), Hernández-Lizoain JL (4), Baixauli J (4), Becerril S (1,2,3), Rotellar F (2,4), Valentí V (2,3,4), Moncada R 2,3,5, Silva C (2,3,6), Salvador J (2,6), Frühbeck G (1,2,3,6). (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (3) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona, Spain.
    (4) Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.

    Oncoimmunology 16 MAY 2017

  • Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation

    Aguiar D (1), Martínez-Urbistondo D (1), D'Avola D (2,3,4), Iñarrairaegui M (2,3,4), Pardo F (3,4,5), Rotellar F (3,4,5), Sangro B (6,3,4), Quiroga J (6,3,4), Herrero JI (2,3,4).

    (1) Department of Internal Medicine, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (2) Liver Unit, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (3) Network Center of Biomedical of Liver and Digestive Diseases Hepáticas y (CIBERehd), Pamplona, Navarra, Spain.
    (4) Institute of Health Research of Navarra (IdiSNA), Pamplona, Navarra, Spain.
    (5) Department of Surgery, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (6) Liver Unite, Clinica Universidad de Navarra, Pamplona, Navarra, Spain. 

    Annals of Transplantation 17 MARCH 2017

  • Agenesis of the dorsal pancreas associated with mucinous cysts and chronic calcific non-alcoholic pancreatitis

    A Cienfuegos J (1), Benito A (2), Rotellar F (3).
    (1) Cirugía/ Apoyo Investigación, Clinica Universidad de Navarra, España.
    (2) Radiología, Clinica Universidad de Navarra, España.
    (3) Cirugía General y Digestiva, Clinica Universidad de Navarra, España. 

    Revista Española de Enfermedades Digestivas 01 MARCH 2017

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra